Viral hepatitis is one of the leading causes of death globally with 1.4 million deaths per year, as many as HIV/AIDS, tuberculosis or malaria. Hepatitis B and C viruses cause 95% of those deaths in the world.1
The WHO global health sector strategy to eliminate Viral Hepatitis as a major public health threat by 2030 requires considerable efforts from governments, healthcare authorities and communities.
Service delivery must be expanded to better manage the number of people living with Hepatitis B Virus (HBV).1
The Need
Efficient Treatment Delivery
Although a vaccine for HBV exists, there is still no cure and lifelong treatment is needed for individuals already chronically infected with Hepatitis B Virus
HBV rapid antibody testing is mainly done at point of care or in community based programmes but HBV viral load testing and monitoring is traditionally done in the laboratory with long turnaround times, which can result in more patients being lost to follow up and care
Service coverage of core interventions are needed to expand prevention, testing and treatment for HBV
The Solution
Xpert HBV Viral Load on the GeneXpert® System
Accurate and reliable quantification of HBV DNA in human serum or plasma
Flexible throughput for any testing setting with round the clock, on-demand results
Simplify disease management with the possibility of having sample to viral load results less than one hour
The Impact
Improve Patient Care: Same day results support better clinical decisions
Increase Efficiency: High quality HBV viral load quantitative results for accurate treatment delivery